Sheltering Arms Hospital Foundation, INC.

Sheltering Arms Hospital Foundation, INC. was paid $26.88M by Medicaid between Jan 2018 and Dec 2024, across 294 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 20% of everything it billed.

33Billing provider infoSHELTERING ARMS HOSPITAL FOUNDATION, INC.
ATHENS, OH 45701

33aNPI1710913462assigned 06/24/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$26.88M

24GClaims889,396

24DCodes billed294

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#44 of 101

Median peer was paid$22.32M

This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BROWNING, MICHAEL controls 15+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	100,584	$2.39M
2019	102,934	$2.43M
2020	87,846	$3.21M
2021	117,749	$3.72M
2022	114,462	$3.51M
2023	231,424	$7.36M
2024incomplete	134,397	$4.26M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
96361	Intravenous infusion, hydration; each additional hour	20%	17,931	14,032	$5.26M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	30,676	26,981	$3.63M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	12%	29,356	26,922	$3.28M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.9%	21,512	18,440	$2.67M
74177	Computed tomography, abdomen and pelvis; with contrast material	6.4%	8,175	7,035	$1.73M
70450	Computed tomography, head or brain; without contrast material	5.7%	7,200	6,335	$1.52M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.5%	6,904	6,308	$661K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.5%	5,471	4,374	$660K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.1%	6,268	5,603	$552K
71275	Computed tomographic angiography, chest, with contrast material	1.6%	2,050	1,759	$424K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	1.6%	3,366	2,761	$422K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.6%	2,188	1,184	$421K

282 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	1,844	$408K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.5%	2,042	$403K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.5%	5,756	$391K
80053	Comprehensive metabolic panel	1.1%	44,490	$285K
G0378	Hospital observation service, per hour	<1%	4,369	$237K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,322	$180K
36415	Collection of venous blood by venipuncture	<1%	60,622	$156K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,380	$140K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	487	$126K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	13,917	$120K
82805		<1%	3,990	$115K
84484		<1%	24,438	$104K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,419	$102K
80048	Basic metabolic panel (calcium, ionized)	<1%	12,911	$100K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,429	$97K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	8,349	$96K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	693	$95K
93976		<1%	744	$91K
59025	Fetal non-stress test	<1%	612	$89K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	701	$88K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	591	$84K
70496		<1%	357	$83K
71046	Radiologic examination, chest; 2 views	<1%	8,593	$68K
71250		<1%	712	$61K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	9,755	$60K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	19,770	$57K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	260	$54K
83605		<1%	18,336	$48K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	555	$47K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	60,820	$46K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	613	$45K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,494	$44K
77063	Screening digital breast tomosynthesis, bilateral	<1%	863	$44K
71045	Radiologic examination, chest; single view	<1%	16,030	$43K
96367		<1%	832	$41K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	10,729	$40K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,350	$38K
70491		<1%	139	$36K
73630		<1%	1,048	$36K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	24,164	$34K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,584	$32K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	129	$32K
80329		<1%	2,302	$31K
76536		<1%	297	$31K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	179	$30K
99214	Doctor's office visit, returning patient (more involved)	<1%	602	$29K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	172	$27K
80320		<1%	3,484	$26K
94060		<1%	309	$25K
72100		<1%	789	$24K
71271		<1%	132	$24K
93971		<1%	357	$24K
J3490	Unclassified drugs	<1%	3,375	$23K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	427	$21K
84443	Thyroid stimulating hormone (TSH)	<1%	6,412	$20K
93017		<1%	236	$20K
73130		<1%	705	$20K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	987	$19K
73610		<1%	709	$19K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	43	$18K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	28	$18K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	99	$17K
73030		<1%	791	$17K
97161		<1%	672	$17K
96368		<1%	283	$17K
73560		<1%	833	$17K
76642		<1%	138	$16K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	160	$16K
74018		<1%	887	$16K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,999	$16K
81001		<1%	35,592	$15K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	42	$15K
64483		<1%	37	$14K
12001		<1%	99	$14K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,581	$14K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	45	$14K
80061	Lipid panel	<1%	1,475	$13K
72131		<1%	221	$13K
82248		<1%	23,111	$12K
96375	Therapeutic injection; each additional sequential IV push	<1%	18,346	$12K
62323		<1%	38	$12K
87040		<1%	6,118	$12K
97162		<1%	348	$12K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	4,645	$11K
73110		<1%	392	$10K
86900		<1%	908	$10K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	878	$10K
90715		<1%	603	$9K
73502		<1%	403	$8K
82077		<1%	7,019	$8K
84703		<1%	15,238	$8K
85610		<1%	14,953	$8K
70486		<1%	171	$7K
70498		<1%	337	$7K
85027		<1%	2,646	$7K
86850		<1%	729	$7K
72050		<1%	130	$7K
83735		<1%	8,471	$6K
86140		<1%	4,707	$6K
87154		<1%	61	$6K
83655		<1%	198	$6K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	13	$6K
73564		<1%	129	$6K
94726		<1%	145	$6K
73080		<1%	203	$6K
96376		<1%	4,341	$6K
82728		<1%	824	$6K
85018		<1%	4,834	$6K
87070		<1%	726	$6K
94729		<1%	201	$6K
36416		<1%	508	$6K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	658	$6K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	79	$5K
97165		<1%	75	$5K
82607		<1%	590	$5K
83880		<1%	4,169	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,472	$5K
83690		<1%	14,816	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	659	$4K
80143		<1%	4,695	$4K
64635		<1%	20	$4K
J7030	Infusion, normal saline solution , 1000 cc	<1%	20,122	$4K
74174		<1%	37	$4K
87077		<1%	1,535	$3K
J3535	Drug administered through a metered dose inhaler	<1%	385	$3K
80361		<1%	151	$3K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	655	$3K
84439		<1%	761	$3K
72072		<1%	82	$3K
45384		<1%	12	$3K
80051		<1%	3,909	$3K
92523		<1%	40	$3K
J1756	Injection, iron sucrose, 1 mg	<1%	85	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	598	$3K
80179		<1%	4,419	$2K
86703		<1%	171	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	7,738	$2K
83540		<1%	722	$2K
71101		<1%	131	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	699	$2K
87480		<1%	335	$2K
93880		<1%	28	$2K
85379		<1%	2,328	$2K
76830	Ultrasound, transvaginal	<1%	185	$2K
83550		<1%	708	$2K
87420		<1%	325	$2K
80353		<1%	169	$2K
80349		<1%	169	$2K
80356		<1%	168	$2K
80076		<1%	3,412	$2K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	444	$2K
83992		<1%	129	$2K
80348		<1%	155	$2K
87186		<1%	1,265	$2K
80373		<1%	151	$2K
80365		<1%	152	$2K
82043		<1%	190	$2K
80358		<1%	151	$2K
82570		<1%	554	$2K
73140		<1%	41	$2K
20552		<1%	13	$2K
80354		<1%	150	$2K
80321		<1%	140	$2K
80324		<1%	141	$1K
80372		<1%	136	$1K
86901		<1%	907	$1K
80359		<1%	129	$1K
80346		<1%	128	$1K
80360		<1%	126	$1K
J1815	Injection, insulin, per 5 units	<1%	781	$1K
82565		<1%	3,992	$1K
85652		<1%	511	$1K
84702		<1%	559	$1K
85730		<1%	4,188	$1K
80362		<1%	114	$1K
87205		<1%	951	$1K
82550		<1%	1,366	$1K
20610		<1%	13	$1K
86803		<1%	140	$985.27
82746		<1%	250	$970.66
82947		<1%	3,931	$950.73
85007		<1%	708	$949.45
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,944	$915.36
87510		<1%	335	$910.04
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	16,958	$879.73
82140		<1%	500	$824.71
J0690	Injection, cefazolin sodium, 500 mg	<1%	765	$814.69
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	8,823	$786.18
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,077	$776.42
84153		<1%	99	$770.51
76870		<1%	17	$678.72
76801		<1%	25	$676.14
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	619	$635.46
83921		<1%	126	$626.52
84520		<1%	3,911	$617.85
80055		<1%	33	$593.19
73552		<1%	13	$585.22
J2770	Injection, quinupristin/dalfopristin, 500 mg (150/350)	<1%	34	$564.02
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	12	$556.86
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,497	$520.23
87899		<1%	35	$519.00
84100		<1%	416	$481.71
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,125	$472.32
80074		<1%	93	$464.37
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,070	$461.49
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	23	$450.76
87653		<1%	14	$444.32
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	300	$419.74
86308		<1%	408	$405.20
80305		<1%	27	$389.60
86592		<1%	79	$358.40
94727		<1%	31	$357.12
36600		<1%	225	$351.30
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	17	$349.75
87075		<1%	300	$346.91
87660		<1%	47	$336.58
73090		<1%	48	$334.30
73590		<1%	66	$333.10
J2704	Injection, propofol, 10 mg	<1%	2,041	$332.66
J2270	Injection, morphine sulfate, up to 10 mg	<1%	901	$317.44
J3360	Injection, diazepam, up to 5 mg	<1%	394	$295.88
51701		<1%	177	$287.04
J7999	Compounded drug, not otherwise classified	<1%	67	$250.37
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,027	$244.50
C9113	Injection, pantoprazole sodium, per vial	<1%	262	$236.84
J0780	Injection, prochlorperazine, up to 10 mg	<1%	858	$229.12
87081		<1%	87	$217.62
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	413	$205.40
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,355	$186.15
J0736	Injection, clindamycin phosphate, 300 mg	<1%	90	$181.28
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	99	$181.01
82010		<1%	190	$176.58
87486		<1%	17	$174.88
80164		<1%	19	$159.04
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	450	$154.20
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,874	$147.02
J7050	Infusion, normal saline solution, 250 cc	<1%	1,631	$142.09
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,808	$132.96
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,364	$124.52
87147		<1%	162	$123.52
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	119	$117.99
84156		<1%	108	$102.97
87581		<1%	17	$100.92
80202		<1%	16	$99.48
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	17	$89.92
J3370	Injection, vancomycin hcl, 500 mg	<1%	310	$87.42
88304		<1%	44	$86.77
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	319	$68.75
80069		<1%	13	$68.26
J1630	Injection, haloperidol, up to 5 mg	<1%	343	$56.39
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	645	$47.03
85014		<1%	14	$45.77
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	95	$41.87
J0703	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg	<1%	103	$41.76
82150		<1%	89	$39.31
83615		<1%	17	$34.14
J2060	Injection, lorazepam, 2 mg	<1%	581	$33.90
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	436	$33.13
87807		<1%	137	$33.00
84550		<1%	24	$28.45
J3480	Injection, potassium chloride, per 2 meq	<1%	327	$25.96
86618		<1%	16	$23.99
J3475	Injection, magnesium sulfate, per 500 mg	<1%	69	$17.25
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	247	$14.16
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	247	$12.59
82962		<1%	97	$11.78
J1644	Injection, heparin sodium, per 1000 units	<1%	216	$11.20
J1940	Injection, furosemide, up to 20 mg	<1%	116	$11.09
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	416	$7.34
J1790	Injection, droperidol, up to 5 mg	<1%	16	$6.42
J0456	Injection, azithromycin, 500 mg	<1%	22	$2.88
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	329	$1.50
J7510	Prednisolone oral, per 5 mg	<1%	14	$1.44
J1171	Injection, hydromorphone, 0.1 mg	<1%	47	$0.45
64636		0%	20	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	20	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	16	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	61	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	78	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	19	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	16	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROWNING, MICHAEL (CFO, OHIOHEALTH)

Parent organizationOHIO HEALTH CORPORATION

Same official

Other billing entities under BROWNING, MICHAEL

Full network →

Provider	Location	Paid
Ohiohealth Corporation	Columbus, OH	$214.99M
Ohiohealth Corporation	Columbus, OH	$76.95M
Ohiohealth Corporation	Columbus, OH	$72.29M
Ohiohealth Corporation	Columbus, OH	$44.08M
Medcentral Health System	Mansfield, OH	$36.92M
Marion General Hospital, INC.	Marion, OH	$36.47M
Ohiohealth Berger Hospital LLC	Circleville, OH	$16.38M
Ohiohealth Corporation	Dublin, OH	$11.81M
Grady Memorial Hospital	Delaware, OH	$9.51M
Hardin Memorial Hospital	Kenton, OH	$7.27M
Medcentral Health System	Mansfield, OH	$3.13M
Madison Family Health Corporation	London, OH	$1.03M
Marion General Hospital, INC.	Marion, OH	$683K
Medcentral Health System	Mansfield, OH	$477K
Sheltering Arms Hospital Foundation	Athens, OH	$435K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.